Testing effectiveness (Phase 2)Study completedNCT04677660What this trial is testingTAK-919 in Healthy Japanese Adults (COVID-19)Who this might be right forCoronavirus Disease (COVID-19) Takeda 200
Not applicableStudy completedNCT04497623What this trial is testingClinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.Who this might be right forCovid19 Fundación Neumologica Colombiana 5
Testing effectiveness (Phase 2)UnknownNCT04840459What this trial is testingUse of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized SettingWho this might be right forCovid19 Sohail Rao 1,000
Not applicableUnknownNCT04561024What this trial is testingEvaluation of a COVID-19 Pneumonia CXR AI Detection AlgorithmWho this might be right forCovid19 Ensemble Group Holdings, LLC 4,000
Not applicableUnknownNCT04627623What this trial is testingPrevalence and Risk Factors of COVID-19 in the Upper Silesian AgglomerationWho this might be right forCovid19Respiratory Tract InfectionsSevere Acute Respiratory Syndrome+4 more Medical University of Silesia 6,000
Not applicableUnknownNCT04570189What this trial is testingEvaluating Auscul-X, a Touch Free Digital StethoscopeWho this might be right forCOVID-19 AusculSciences Canada Inc. 40
Not applicableStudy completedNCT04376879What this trial is testingPredicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)Who this might be right forCOVID-19 Central Hospital, Nancy, France 301
Early research (Phase 1)Ended earlyNCT04501796What this trial is testingA Trial of NT-I7 in COVID-19 (SPESELPIS)Who this might be right forCOVID-19 NeoImmuneTech 7
Not applicableStudy completedNCT04546191What this trial is testingSymptoms and Wellbeing of People Infected With Covid-19 Virus in IcelandWho this might be right forCovid19 Landspitali University Hospital 1,580
Not applicableLooking for participantsNCT04362150What this trial is testingLong-term Impact of Infection With Novel Coronavirus (COVID-19)Who this might be right forCOVID University of California, San Francisco 800
Testing effectiveness (Phase 2)Study completedNCT04402060What this trial is testingAPL-9 in Adults With Mild to Moderate ARDS Due to COVID-19Who this might be right forCOVIDCovid-19Coronavirus+6 more Apellis Pharmaceuticals, Inc. 72
Early research (Phase 1)UnknownNCT06205524What this trial is testingEvealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy AdultsWho this might be right forCOVID-19COVID-19 Immunisation National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College 100
Testing effectiveness (Phase 2)Study completedNCT05721144What this trial is testingInhaled NO in Surgical Patients With Recent COVID-19 InfectionWho this might be right forNitric OxideCOVID-19Surgery+1 more Xijing Hospital 660
Not applicableUnknownNCT04713163What this trial is testingCOVID-19 Vaccine Induced ImmunityWho this might be right forCovid19 University of Manitoba 200
Large-scale testing (Phase 3)Study completedNCT04894721What this trial is testingProphylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)Who this might be right forCovid19 Ministry of Public Health, Argentina 172
Very early researchUnknownNCT04371601What this trial is testingSafety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019Who this might be right forCOVID-19 Pneumonia Fuzhou General Hospital 60
Large-scale testing (Phase 3)UnknownNCT04319900What this trial is testingClinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus PneumoniaWho this might be right forNovel Coronavirus Pnuemonia Beijing Chao Yang Hospital 150
Large-scale testing (Phase 3)Ended earlyNCT05639192What this trial is testingAsunercept for the Treatment of Patients With Moderate to Severe COVID-19 DiseaseWho this might be right forCOVID-19 Apogenix GmbH 34
Early research (Phase 1)Active Not RecruitingNCT07183709What this trial is testingSafety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in AdultsWho this might be right forCOVID-19 National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT05531032What this trial is testingHRQOL of Life After ECMO Due to COVID-19.Who this might be right forARDSCOVID-19 PneumoniaExtracorporeal Membrane Oxygenation Medical University of Vienna 44